Summary:
- The National Institutes of Health (NIH) is considering restructuring its HIV/AIDS research budget to focus more on prevention efforts, following recent breakthroughs in HIV prevention methods.
- Researchers have developed new tools, such as long-acting injectable drugs and pre-exposure prophylaxis (PrEP), that can significantly reduce the risk of HIV transmission, and the NIH wants to allocate more funding to scale up the use of these prevention strategies.
- The proposed changes aim to shift the balance of the NIH's HIV/AIDS research portfolio from a primarily treatment-focused approach to one that emphasizes both treatment and prevention, in order to make the most of the latest scientific advancements and have a greater impact on the HIV/AIDS epidemic.